Copyright Reports & Markets. All rights reserved.

Global and United States Generic Medicine Market 2020 by Company, Type and Application, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Product Overview and Scope of Generic Medicine
    • 1.2 Classification of Generic Medicine by Type
      • 1.2.1 Overview: Global Generic Medicine Revenue by Type: 2015 Versus 2019 Versus 2025
      • 1.2.2 Global Generic Medicine Revenue Market Share by Type in 2019
      • 1.2.3 Simple Generic Drugs
      • 1.2.4 Super Generic Drugs
      • 1.2.5 Biosimilars
      • 1.2.6 By Application:
      • 1.2.7 CNS
      • 1.2.8 Cardiovascular
      • 1.2.9 Respiratory
      • 1.2.10 Rheumatology
      • 1.2.11 Diabetes
      • 1.2.12 Oncology
    • 1.3 Global Generic Medicine Market by Application
      • 1.3.1 Overview: Global Generic Medicine Revenue by Application: 2015 Versus 2019 Versus 2025
      • 1.3.2 CNS
      • 1.3.3 Cardiovascular
      • 1.3.4 Respiratory
      • 1.3.5 Rheumatology
      • 1.3.6 Diabetes
      • 1.3.7 Oncology
      • 1.3.8 Others
    • 1.4 Global Generic Medicine Market Size and Forecast (2015-2025)
    • 1.5 Global Generic Medicine Market Size by Regions: 2015 VS 2019 VS 2025
    • 1.6 Global Generic Medicine Market Size by Regions (2015-2020)
    • 1.7 Global Generic Medicine Market Size and Forecast by Regions (2020-2025)
      • 1.7.1 North America Generic Medicine Status and Prospect (2015-2025)
      • 1.7.2 Europe Generic Medicine Status and Prospect (2015-2025)
      • 1.7.3 Asia Generic Medicine Status and Prospect (2015-2025)
      • 1.7.4 South America Generic Medicine Status and Prospect (2015-2025)
      • 1.7.5 Middle East & Africa Generic Medicine Status and Prospect (2015-2025)

    2 Company Profiles

    • 2.1 Teva
      • 2.1.1 Teva Details
      • 2.1.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Teva SWOT Analysis
      • 2.1.4 Teva Product and Services
      • 2.1.5 Teva Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 Sanofi
      • 2.2.1 Sanofi Details
      • 2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 Sanofi SWOT Analysis
      • 2.2.4 Sanofi Product and Services
      • 2.2.5 Sanofi Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Sun Pharmaceutical
      • 2.3.1 Sun Pharmaceutical Details
      • 2.3.2 Sun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Sun Pharmaceutical SWOT Analysis
      • 2.3.4 Sun Pharmaceutical Product and Services
      • 2.3.5 Sun Pharmaceutical Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Novartis - Sandoz
      • 2.4.1 Novartis - Sandoz Details
      • 2.4.2 Novartis - Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Novartis - Sandoz SWOT Analysis
      • 2.4.4 Novartis - Sandoz Product and Services
      • 2.4.5 Novartis - Sandoz Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 Pfizer (Hospira)
      • 2.5.1 Pfizer (Hospira) Details
      • 2.5.2 Pfizer (Hospira) Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 Pfizer (Hospira) SWOT Analysis
      • 2.5.4 Pfizer (Hospira) Product and Services
      • 2.5.5 Pfizer (Hospira) Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 Mylan
      • 2.6.1 Mylan Details
      • 2.6.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 Mylan SWOT Analysis
      • 2.6.4 Mylan Product and Services
      • 2.6.5 Mylan Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 Lupin
      • 2.7.1 Lupin Details
      • 2.7.2 Lupin Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 Lupin SWOT Analysis
      • 2.7.4 Lupin Product and Services
      • 2.7.5 Lupin Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 Fresenius Kabi
      • 2.8.1 Fresenius Kabi Details
      • 2.8.2 Fresenius Kabi Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 Fresenius Kabi SWOT Analysis
      • 2.8.4 Fresenius Kabi Product and Services
      • 2.8.5 Fresenius Kabi Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 Aspen
      • 2.9.1 Aspen Details
      • 2.9.2 Aspen Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 Aspen SWOT Analysis
      • 2.9.4 Aspen Product and Services
      • 2.9.5 Aspen Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 Aurobindo
      • 2.10.1 Aurobindo Details
      • 2.10.2 Aurobindo Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 Aurobindo SWOT Analysis
      • 2.10.4 Aurobindo Product and Services
      • 2.10.5 Aurobindo Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.11 Stada Arzneimittel
      • 2.11.1 Stada Arzneimittel Details
      • 2.11.2 Stada Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.11.3 Stada Arzneimittel SWOT Analysis
      • 2.11.4 Stada Arzneimittel Product and Services
      • 2.11.5 Stada Arzneimittel Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.12 Valeant
      • 2.12.1 Valeant Details
      • 2.12.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.12.3 Valeant SWOT Analysis
      • 2.12.4 Valeant Product and Services
      • 2.12.5 Valeant Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.13 Dr. Reddy's
      • 2.13.1 Dr. Reddy's Details
      • 2.13.2 Dr. Reddy's Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.13.3 Dr. Reddy's SWOT Analysis
      • 2.13.4 Dr. Reddy's Product and Services
      • 2.13.5 Dr. Reddy's Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.14 Hikma
      • 2.14.1 Hikma Details
      • 2.14.2 Hikma Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.14.3 Hikma SWOT Analysis
      • 2.14.4 Hikma Product and Services
      • 2.14.5 Hikma Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.15 Krka Group
      • 2.15.1 Krka Group Details
      • 2.15.2 Krka Group Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.15.3 Krka Group SWOT Analysis
      • 2.15.4 Krka Group Product and Services
      • 2.15.5 Krka Group Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.16 ENDO (Par Pharmaceutical)
      • 2.16.1 ENDO (Par Pharmaceutical) Details
      • 2.16.2 ENDO (Par Pharmaceutical) Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.16.3 ENDO (Par Pharmaceutical) SWOT Analysis
      • 2.16.4 ENDO (Par Pharmaceutical) Product and Services
      • 2.16.5 ENDO (Par Pharmaceutical) Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.17 Apotex
      • 2.17.1 Apotex Details
      • 2.17.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.17.3 Apotex SWOT Analysis
      • 2.17.4 Apotex Product and Services
      • 2.17.5 Apotex Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.18 Zydus Cadila
      • 2.18.1 Zydus Cadila Details
      • 2.18.2 Zydus Cadila Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.18.3 Zydus Cadila SWOT Analysis
      • 2.18.4 Zydus Cadila Product and Services
      • 2.18.3 Zydus Cadila Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.19 Nichi-Iko Pharmaceutical
      • 2.19.1 Nichi-Iko Pharmaceutical Details
      • 2.19.2 Nichi-Iko Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.19.3 Nichi-Iko Pharmaceutical SWOT Analysis
      • 2.19.4 Nichi-Iko Pharmaceutical Product and Services
      • 2.19.5 Nichi-Iko Pharmaceutical Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)
    • 2.20 Cipla
      • 2.20.1 Cipla Details
      • 2.20.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.20.3 Cipla SWOT Analysis
      • 2.20.4 Cipla Product and Services
      • 2.20.5 Cipla Generic Medicine Revenue, Gross Margin and Market Share (2018-2019)

    3 Market Competition, by Players

    • 3.1 Global Generic Medicine Market Size by Players (2015-2020)
    • 3.2 United States Generic Medicine Market Size by Players (2015-2020)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 5 Generic Medicine Players Market Share
      • 3.3.2 Top 10 Generic Medicine Players Market Share

    4 North America Market Size and Forecast by Countries

    • 4.1 North America Generic Medicine Market Size by Countries (2015-2020)
    • 4.2 North America Generic Medicine Market Size and Forecast by Countries (2015-2026)
    • 4.3 United States Generic Medicine Market Size and Forecast (2015-2025)
    • 4.4 Canada Generic Medicine Market Size and Forecast (2015-2025)
    • 4.5 Mexico Generic Medicine Market Size and Forecast (2015-2025)

    5 Europe Market Size and Forecast by Countries

    • 5.1 Europe Generic Medicine Market Size by Countries (2015-2020)
    • 5.2 Europe Generic Medicine Market Size and Forecast by Countries (2015-2026)
    • 5.3 Germany Generic Medicine Market Size and Forecast (2015-2025)
    • 5.4 France Generic Medicine Market Size and Forecast (2015-2025)
    • 5.5 UK Generic Medicine Market Size and Forecast (2015-2025)
    • 5.6 Russia Generic Medicine Market Size and Forecast (2015-2025)
    • 5.7 Italy Generic Medicine Market Size and Forecast (2015-2025)

    6 Asia-Pacific Market Size and Forecast by Countries

    • 6.1 Asia-Pacific Generic Medicine Market Size by Regions (2015-2020)
    • 6.2 Asia-Pacific Generic Medicine Market Size and Forecast by Regions (2015-2026)
    • 6.3 China Generic Medicine Market Size and Forecast (2015-2025)
    • 6.4 Japan Generic Medicine Market Size and Forecast (2015-2025)
    • 6.5 Korea Generic Medicine Market Size and Forecast (2015-2025)
    • 6.6 India Generic Medicine Market Size and Forecast (2015-2025)
    • 6.7 Southeast Asia Generic Medicine Market Size and Forecast (2015-2025)

    7 South America Market Size and Forecast by Countries

    • 7.1 South America Generic Medicine Market Size by Countries (2015-2020)
    • 7.2 South America Generic Medicine Market Size and Forecast by Countries (2015-2026)
    • 7.3 Brazil Generic Medicine Market Size and Forecast (2015-2025)
    • 7.4 Argentina Generic Medicine Market Size and Forecast (2015-2025)

    8 Middle East & Africa Market Size and Forecast by Countries

    • 8.1 Middle East & Africa Generic Medicine Revenue by Regions (2015-2020)
    • 8.2 Middle East & Africa Generic Medicine Market Size and Forecast by Countries (2015-2026)
    • 8.3 Saudi Arabia Generic Medicine Market Size and Forecast (2015-2025)
    • 8.4 UAE Generic Medicine Market Size and Forecast (2015-2025)
    • 8.5 Egypt Generic Medicine Market Size and Forecast (2015-2025)
    • 8.6 South Africa Generic Medicine Market Size and Forecast (2015-2025)

    9 Market Size Segment by Type

    • 9.1 Global Generic Medicine Market Size and Forecast by Type (2015-2025)
      • 9.1.1 Global Generic Medicine Market Size by Type (2015-2020)
      • 9.1.2 Global Generic Medicine Market Size Forecast by Type (2020-2025)
    • 9.2 United States Generic Medicine Market Size and Forecast by Type (2015-2025)
      • 9.2.1 United States Generic Medicine Market Size by Type (2015-2020)
      • 9.2.2 United States Generic Medicine Market Size Forecast by Type (2020-2025)

    10 Market Size Segment by Application

    • 10.1 Global Generic Medicine Market Size and Forecast by Application (2015-2025)
      • 10.1.1 Global Generic Medicine Market Size by Application (2015-2020)
      • 10.1.2 Global Generic Medicine Market Size Forecast by Application (2020-2025)
    • 10.2 United States Generic Medicine Market Size and Forecast by Application (2015-2025)
      • 10.2.1 United States Generic Medicine Market Size by Application (2015-2020)
      • 10.2.2 United States Generic Medicine Market Size Forecast by Application (2020-2025)

    11 Research Findings and Conclusion

      12 Appendix

      • 12.1 Methodology
      • 12.2 Data Source
      • 12.3 Disclaimer

      Market Overview
      The global Generic Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

      The Generic Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

      Market segmentation
      Generic Medicine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

      Breakdown by Type, Generic Medicine market has been segmented into Simple Generic Drugs, Super Generic Drugs, Biosimilars, By Application:, CNS, Cardiovascular, Respiratory, Rheumatology, Diabetes, etc.

      Breakdown by Application, Generic Medicine has been segmented into CNS, Cardiovascular, Respiratory, Rheumatology, Diabetes, Oncology, Others, etc.

      Regions and Countries Level Analysis
      Regional analysis is another highly comprehensive part of the research and analysis study of the global Generic Medicine market presented in the report. This section sheds light on the sales growth of different regional and country-level Generic Medicine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Generic Medicine market.

      For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.

      Competitive Landscape and Generic Medicine Market Share Analysis
      Generic Medicine competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Generic Medicine revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Generic Medicine revenue and market share for each player covered in this report.

      The major players covered in Generic Medicine are: Teva, Sanofi, Sun Pharmaceutical, Novartis - Sandoz, Pfizer (Hospira), Mylan, Lupin, Fresenius Kabi, Aspen, Aurobindo, Stada Arzneimittel, Valeant, Dr. Reddy's, Hikma, Krka Group, ENDO (Par Pharmaceutical), Apotex, Zydus Cadila, Nichi-Iko Pharmaceutical, Cipla, etc. Among other players domestic and global, Generic Medicine market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

      Market segment by players, this report covers
      Teva
      Sanofi
      Sun Pharmaceutical
      Novartis - Sandoz
      Pfizer (Hospira)
      Mylan
      Lupin
      Fresenius Kabi
      Aspen
      Aurobindo
      Stada Arzneimittel
      Valeant
      Dr. Reddy's
      Hikma
      Krka Group
      ENDO (Par Pharmaceutical)
      Apotex
      Zydus Cadila
      Nichi-Iko Pharmaceutical
      Cipla

      Market segment by regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
      South America (Brazil, Argentina)
      MENA (Saudi Arabia, UAE, Turkey and South Africa)

      Market segment by Type, covers:
      Simple Generic Drugs
      Super Generic Drugs
      Biosimilars
      By Application:
      CNS
      Cardiovascular
      Respiratory
      Rheumatology
      Diabetes
      Oncology

      Market segment by Application, can be divided into
      CNS
      Cardiovascular
      Respiratory
      Rheumatology
      Diabetes
      Oncology
      Others
      Buy now